The national cervical screening programme, CervicalCheck, commenced in Ireland in 2008.
Free cervical smear tests are offered to over 1.2 million women aged 25–60 every 3 (aged …

Cervical cancer incidence and mortality can be reduced substantially by organised
cytological screening at 3 to 5 year intervals, as was demonstrated in the Nordic countries …

The landscape of cervical cancer prevention is changing in many countries thanks to the
introduction of vaccination against high‐risk types of human papillomavirus (HPV) and the …

Prior to the introduction of a national cervical screening programme, death rates from
cervical cancer in the Republic of Ireland were greater than the death rates in all other …

Objective To review the first two years of the primary human papillomavirus (HPV) cervical
screening programme in an HPV vaccinated population. Design Observational study …

Cervical screening in England is provided free of charge by the National Health Service to
all women aged 20–64 years. Computerised call and recall was introduced in 1988 and …

This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …

The success of screening, an important cancer prevention tool, depends on the quality and
efficiency of protocols and guidelines for screening and follow‐up. However, even centrally …

Key content: An organised screening programme has reduced the incidence of cervical
cancer in the UK. Cervical screening aims to detect and treat premalignant, low‐or high …

Background In 2017, the Australian National Cervical Screening Program (NCSP)
implemented five‐yearly primary human papillomavirus (HPV) screening for women aged …